Back to top
more

CORE LABS INC (CLB)

(Delayed Data from NYSE)

$14.30 USD

14.30
460,181

+0.19 (1.35%)

Updated Feb 23, 2024 04:00 PM ET

After-Market: $14.30 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.18%
2Buy17.85%
3Hold9.34%
4Sell5.12%
5Strong Sell2.62%
S&P50010.88%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 35% (164 out of 251)

Industry: Oil and Gas - Field Services

Better trading starts here.

Balance Sheet

Research for CLB

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Core Laboratories Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 15 15 18 14 11
Receivables 123 115 107 93 138
Notes Receivable 0 0 0 0 0
Inventories 72 60 45 38 50
Other Current Assets 13 21 19 21 22
Total Current Assets 223 212 189 166 221
Net Property & Equipment 100 105 111 115 124
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 69 69 70 73 67
Intangibles 106 107 108 108 231
Deposits & Other Assets 34 34 41 40 56
Total Assets 586 578 581 569 775
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 34 46 30 23 36
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 25 28 27 33 35
Income Taxes Payable 7 3 7 8 6
Other Current Liabilities 12 14 15 14 23
Total Current Liabilities 88 103 91 90 112
Mortgages 0 0 0 0 0
Deferred Taxes/Income 13 23 24 21 27
Convertible Debt 0 0 0 0 0
Long-Term Debt 163 172 189 259 305
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 51 53 67 67 84
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 357 389 420 493 593
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 1 1 1 1
Capital Surplus 110 102 101 41 52
Retained Earnings 121 86 68 50 161
Other Equity 0 1 -6 -3 -2
Treasury Stock 1 1 4 14 29
Total Shareholder's Equity 230 189 161 76 182
Total Liabilities & Shareholder's Equity 586 578 581 569 775
Total Common Equity 230 189 161 76 182
Shares Outstanding 46.72 46.37 46.20 44.50 44.30
Book Value Per Share 4.92 4.07 3.48 1.70 4.11

Fiscal Year End for Core Laboratories Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022
Assets          
Cash & Equivalents 15 17 26 16 15
Receivables 109 121 121 124 115
Notes Receivable 0 0 0 0 0
Inventories 72 75 72 67 60
Other Current Assets 27 15 17 20 21
Total Current Assets 223 229 236 228 212
Net Property & Equipment 100 100 102 102 105
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 69 72 69 67 69
Intangibles 216 107 107 107 107
Deposits & Other Assets 34 32 33 33 34
Total Assets 593 592 602 594 578
Liabilities & Shareholders Equity 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022
Notes Payable 0 0 0 0 0
Accounts Payable 34 34 39 38 46
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 25 23 25 27 28
Income Taxes Payable 7 5 7 5 3
Other Current Liabilities 44 13 14 14 14
Total Current Liabilities 87 84 96 96 103
Mortgages 0 0 0 0 0
Deferred Taxes/Income 13 12 12 22 23
Convertible Debt 0 0 0 0 0
Long-Term Debt 163 178 183 180 172
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 66 49 51 53
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 359 363 382 393 389
Shareholders Equity 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022
Preferred Stock 0 0 0 0 0
Common Stock (Par) 0 0 0 1 1
Capital Surplus 110 109 108 111 102
Retained Earnings 121 119 110 88 86
Other Equity 0 1 1 1 1
Treasury Stock 1 0 0 1 1
Total Shareholder's Equity 234 229 220 200 189
Total Liabilities & Shareholder's Equity 593 592 602 594 578
Total Common Equity 234 229 220 200 189
Shares Outstanding 46.72 46.72 46.60 46.60 46.30
Book Value Per Share 5.01 4.91 4.71 4.30 4.08